Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probucol and Cilostazol in Severe Hypercholesterolemia
NCT02098460Phase 4Completed
- Sponsor
- Otsuka Holdings
- Start
- Oct 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in hypercholesterolemia, sponsored by Otsuka Holdings. Started Oct 2013; status: completed.
02
Drugs
cilostazol
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02098460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098460.